Results per Page:
Dr. Elizabeth Halloran, expert in vaccine trial design and quantitative methods for infectious diseases, transitions to emerita
Infectious disease modeling pioneer helped outline modern precepts for design and analysis of vaccine trials, causal inference with interference; shaped a generation of infectious disease scientists
Starting the year smarter
How patients, providers, researchers and others stay informed amid a deluge of data and information
Pertussis vaccination coverage and incidence in King County, Washington
From the Halloran Group, Biostatistics, Bioinformatics, and Epidemiology Program, Vaccine and Infectious Disease Division
Latest Fred Hutch research on COVID-19
How Hutch scientists have been tackling coronavirus in lab and clinic
What Hutch coronavirus experts are saying about omicron
Some answers, but many questions, about highly mutated new variant of COVID-19 virus
Will SARS-CoV-2 become endemic?
From the Halloran lab, Biostatistics, Bioinformatics, and Epidemiology Program, Vaccine and Infectious Disease Division
There’s no crystal ball for modeling the pandemic
Mathematical modelers explain challenges, limitations of their work to predict COVID-19 outcomes
Media timeline: coronavirus coverage
A timeline of key articles about our efforts around COVID-19
COVID-19: What our scientists are saying
Fred Hutch researchers provide their insights and ideas on the pandemic
Dr. M. Elizabeth ‘Betz’ Halloran elected to National Academy of Medicine
Statistician honored for helping the world anticipate, manage and prevent infectious disease outbreaks
Dr. M. Elizabeth ‘Betz’ Halloran receives Nathan Mantel Lifetime Achievement Award
Biostatistician honored for her landmark contributions to statistical methods for infectious disease epidemiology
First licensed dengue vaccine withstands rainy season
From the Vaccine and Infectious Disease Division
New partnership seeks to increase access to lifesaving stem-cell transplants
Celebrating faculty and staff achievements
Genomic sequencing offers new clues to Zika's spread from Brazil to the Caribbean to Miami
Genomic sequencing offers new clues to the virus’ spread from Brazil to the Caribbean to Miami
Good News: Dr. Betz Halloran wins award in Rome; Hutch nominated for SLU nonprofit of the year; Obliteride amassed $2.4M in donations
Celebrating faculty and staff achievements
Tracking the rise and fall of Ebola in Sierra Leone
Study pins numbers on outbreak’s devastation, interventions that worked
Zika virus: 6 key things we don’t yet know
From lack of data to inconclusive blood tests to the unique challenges of pregnancy, experts weigh in on the knowledge gaps in this emerging infection
Fred Hutchinson Cancer Research Center designated MIDAS Center of Excellence
Designation puts Fred Hutch on cutting edge of U.S. analysis and response to infectious disease outbreaks around the globe - Center includes researchers from seven other academic sites across the country
‘It packs a punch’: High-dose flu vaccine cuts illness in older adults
Shot contains 4 times as much antigen, boosts antibodies and protects better, large study finds
Oral vaccine could have halved Haiti’s cholera epidemic
VIDD study shows need for comprehensive global action plan, strategy to reduce cholera-related mortality in developing countries